Key result
Long-term treatment with trandolapril in rats with myocardial infarction significantly attenuated the increase in myocardial Hsp60 content, improved hemodynamics including LVEDP, and preserved mitochondrial function.
Why the study?
Does trandolapril attenuate the increase in Hsp60 and improve mitochondrial function in a rat model of post-myocardial infarction heart failure?
Does trandolapril attenuate the increase in Hsp60 and improve mitochondrial function in a rat model of post-myocardial infarction heart failure?
Trandolapril attenuates the increase in Hsp60 and improves mitochondrial function in failing hearts after myocardial infarction, suggesting these mechanisms contribute to its beneficial effects in chronic heart failure.
Answers are grounded in this paper and cite their sources.
Identifies Hsp60 and mitochondrial pathways as potential post-MI targets; hypothesis-generating in rats and leaves open human translation.
Changes in heat shock protein (Hsp) 60 of the viable left ventricular muscle (viable LV) after myocardial infarction in rats and the effect of the angiotensin I-converting enzyme inhibitor (ACEI) trandolapril were examined. Myocardial infarction was induced in rats by ligation of the left coronary artery. The coronary artery-ligated (CAL) and sham-operated (Sham) rats were orally treated with 3 mg/kg/d trandolapril from the 2nd to 8th week after surgery. Hemodynamic parameters and tissue weights of the left and right ventricles of the animals at the 8th week after CAL (8w-CAL rats) showed signs indicating chronic heart failure. An increase in Hsp60 content, a decrease in mitochondrial oxygen consumption rate (OCR), and an increase in the mitochondrial thiobarbiturate-reacting substance (TRS) of the viable LV were detected. Eight weeks after CAL. Long-term treatment of the CAL rats with trandolapril improved the hemodynamic parameters, attenuated the CAL-induced increase in Hsp60 content, the decrease in mitochondrial OCR, and the increase in the mitochondrial TRS content of the viable LV at the 8th week after myocardial infarction. The increase in Hsp60 content was closely related to the decrease in the mitochondrial OCR and to a rise in the LVEDP of the CAL animal at the 8th week after myocardial infarction. These results suggest that a series of pathophysiological alterations, including a reduction in mitochondrial function, appearance of reactive oxygen stress, and production of Hsp60 is involved in the development of cardiac failure and that trandolapril is beneficial for preventing these alterations.
No takes yet. Share an insight, caveat, or question.
Toga et al. (2007) studied Myocardial infarction and chronic heart failure. Trandolapril vs. Vehicle (0.25% carboxymethylcellulose sodium) was evaluated on Left ventricular end-diastolic pressure (LVEDP) at 8 weeks (mmHg) (p=<0.05). Long-term treatment with trandolapril in rats with myocardial infarction significantly attenuated the increase in myocardial Hsp60 content, improved hemodynamics including LVEDP, and preserved mitochondrial function.
Synapse has enriched 10 related papers. Consider them for comparative context: